Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...
W. L. Gore & Associates' medical business (Gore) today announced U.S. Food and Drug Administration approval of an expanded indication for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX ...
The balloon-expandable device can now be used as a bridge in fenestrated and branched endovascular aortic repair.
The GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis indication expansion brings the first bridging stent device with dual indication for both fenestrated and branched endovascular repair*.
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has approved the GORE ® VIABAHN ® Endoprosthesis for interventional ...
This study aims to compare the GORE ® VIABAHN ® VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with ...
Vascular. 2007;15(3):154-157. We limit use of the Viabahn stent graft to arteries with an endoluminal diameter of ≥ 4.5 mm. We do not use this technique in endarterectomized or circumferentially ...
A heparin-coated endovascular prosthesis has received approval from the US Food and Drug Administration (FDA) for treatment of stenosis or thrombotic occlusions at the venous anastomosis of synthetic ...
Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company's Viabahn VBX ...
The expanded indication covers the device’s use as a bridging stent in fenestrated and branched aortic repair.
We used the Viabahn stent graft (W. L. Gore & Associates, Flagstaff AZ) to perform laparoscopy-assisted left aortorenal bypass in three cases. In doing so, we modified a technique originally performed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results